Literature DB >> 27804986

The translational potential of microRNAs as biofluid markers of urological tumours.

Annika Fendler1,2,3, Carsten Stephan2,3, George M Yousef4, Glen Kristiansen5, Klaus Jung2,3.   

Abstract

MicroRNAs (miRNAs) are secreted by cells in vesicles, bound in a ribonucleoprotein complex or as free molecules. These miRNA secretion pathways are dysregulated in cancer, making miRNAs attractive candidate molecules for liquid biopsies. A number of studies have investigated the regulation of miRNA secretion into blood and urine and suggested that miRNAs are noninvasive diagnostic, prognostic and surveillance markers in urological carcinomas, and research in this area has increased over the past 5 years. However, methodological and analytical pitfalls exist and require addressing to enable future translation of the laboratory findings regarding miRNAs as biomarkers into clinical practice in bladder cancer, kidney cancer, prostate cancer and testicular cancer.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27804986     DOI： 10.1038/nrurol.2016.193

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


  136 in total

1.  The somatic genomic landscape of chromophobe renal cell carcinoma.

Authors:  Caleb F Davis; Christopher J Ricketts; Min Wang; Lixing Yang; Andrew D Cherniack; Hui Shen; Christian Buhay; Hyojin Kang; Sang Cheol Kim; Catherine C Fahey; Kathryn E Hacker; Gyan Bhanot; Dmitry A Gordenin; Andy Chu; Preethi H Gunaratne; Michael Biehl; Sahil Seth; Benny A Kaipparettu; Christopher A Bristow; Lawrence A Donehower; Eric M Wallen; Angela B Smith; Satish K Tickoo; Pheroze Tamboli; Victor Reuter; Laura S Schmidt; James J Hsieh; Toni K Choueiri; A Ari Hakimi; Lynda Chin; Matthew Meyerson; Raju Kucherlapati; Woong-Yang Park; A Gordon Robertson; Peter W Laird; Elizabeth P Henske; David J Kwiatkowski; Peter J Park; Margaret Morgan; Brian Shuch; Donna Muzny; David A Wheeler; W Marston Linehan; Richard A Gibbs; W Kimryn Rathmell; Chad J Creighton
Journal:  Cancer Cell       Date:  2014-08-21       Impact factor: 31.743

2.  Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer.

Authors:  Fulya Yaman Agaoglu; Müge Kovancilar; Yavuz Dizdar; Emin Darendeliler; Stefan Holdenrieder; Nejat Dalay; Ugur Gezer
Journal:  Tumour Biol       Date:  2011-01-28

3.  miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.

Authors:  Patricia Puerta-Gil; Rodrigo García-Baquero; Angela Y Jia; Sara Ocaña; Miguel Alvarez-Múgica; Jose L Alvarez-Ossorio; Carlos Cordon-Cardo; Fernando Cava; Marta Sánchez-Carbayo
Journal:  Am J Pathol       Date:  2012-03-15       Impact factor: 4.307

4.  MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples.

Authors:  Melanie von Brandenstein; Jency J Pandarakalam; Lukas Kroon; Heike Loeser; Jan Herden; Gabriele Braun; Katherina Wendland; Hans P Dienes; Udo Engelmann; Ullrich Engelmann; Jochen W U Fries
Journal:  Am J Pathol       Date:  2012-03-17       Impact factor: 4.307

5.  Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.

Authors:  Luke A Selth; Scott Townley; Joanna L Gillis; Aleksandra M Ochnik; Krisna Murti; Robyn J Macfarlane; Kim N Chi; Villis R Marshall; Wayne D Tilley; Lisa M Butler
Journal:  Int J Cancer       Date:  2011-11-03       Impact factor: 7.396

6.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

7.  Is relative quantification dispensable for the measurement of microRNAs as serum biomarkers in germ cell tumors?

Authors:  Meike Spiekermann; Klaus-Peter Dieckmann; Thomas Balks; Jörn Bullerdiek; Gazanfer Belge
Journal:  Anticancer Res       Date:  2015-01       Impact factor: 2.480

8.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

9.  Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer.

Authors:  Stephanie Kriebel; Doris Schmidt; Stefan Holdenrieder; Diane Goltz; Glen Kristiansen; Rudolf Moritz; Christian Fisang; Stefan C Müller; Jörg Ellinger
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

10.  Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia.

Authors:  Heather H Cheng; Patrick S Mitchell; Evan M Kroh; Alexander E Dowell; Lisly Chéry; Javed Siddiqui; Peter S Nelson; Robert L Vessella; Beatrice S Knudsen; Arul M Chinnaiyan; Kenneth J Pienta; Colm Morrissey; Muneesh Tewari
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240
View more
  45 in total

Review 1.  Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease.

Authors:  Marcelo A Mori; Raissa G Ludwig; Ruben Garcia-Martin; Bruna B Brandão; C Ronald Kahn
Journal:  Cell Metab       Date:  2019-08-22       Impact factor: 27.287

2.  Holding a MIRror up to the robustness of the prostate cancer urinary transcriptome.

Authors:  Adele E Connor; Asia C Jordan; Antoinette S Perry
Journal:  Transl Androl Urol       Date:  2019-12

Review 3.  MicroRNAs: Key Players in Bladder Cancer.

Authors:  Qi Li; Helei Wang; Hourong Peng; Qiuping Huang; Ting Huyan; Qingsheng Huang; Hui Yang; Junling Shi
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

4.  Urinary microRNAome in healthy cats and cats with pyelonephritis or other urological conditions.

Authors:  Marta Gòdia; Louise Brogaard; Emilio Mármol-Sánchez; Rebecca Langhorn; Ida Nordang Kieler; Bert Jan Reezigt; Lise Nikolic Nielsen; Lisbeth Rem Jessen; Susanna Cirera
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

5.  Size-Exclusion Chromatography Separation Reveals That Vesicular and Non-Vesicular Small RNA Profiles Differ in Cell Free Urine.

Authors:  Jenni Karttunen; Sarah E Stewart; Lajos Kalmar; Andrew J Grant; Fiona E Karet Frankl; Tim L Williams
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

6.  Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer.

Authors:  Heather H Cheng; Melissa Plets; Hongli Li; Celestia S Higano; Catherine M Tangen; Neeraj Agarwal; Nicholas J Vogelzang; Maha Hussain; Ian M Thompson; Muneesh Tewari; Evan Y Yu
Journal:  Prostate       Date:  2017-11-06       Impact factor: 4.104

7.  The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer.

Authors:  Lucia Cicchillitti; Rahma Said; Nouha Setti Boubaker; Aymone Gurtner; Haroun Ayed; Ahlem Blel; Omar Karray; Mohamed Ali Essid; Maroua Gharbi; Abderrazek Bouzouita; Soumaya Rammeh Rommeni; Mohamed Chebil; Giulia Piaggio; Slah Ouerhani
Journal:  Mol Biol Rep       Date:  2019-06-18       Impact factor: 2.316

8.  "Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical Trials.

Authors:  Matthew J Murray; Hannah L Watson; Dawn Ward; Shivani Bailey; Marta Ferraresso; James C Nicholson; Vincent J Gnanapragasam; Benjamin Thomas; Cinzia G Scarpini; Nicholas Coleman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-12-18       Impact factor: 4.254

Review 9.  The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research.

Authors:  Saumya Das; K Mark Ansel; Markus Bitzer; Xandra O Breakefield; Alain Charest; David J Galas; Mark B Gerstein; Mihir Gupta; Aleksandar Milosavljevic; Michael T McManus; Tushar Patel; Robert L Raffai; Joel Rozowsky; Matthew E Roth; Julie A Saugstad; Kendall Van Keuren-Jensen; Alissa M Weaver; Louise C Laurent
Journal:  Cell       Date:  2019-04-04       Impact factor: 66.850

10.  Evaluation of microRNA 92a Expression and Its Target Protein Bim in Colorectal Cancer.

Authors:  Ahmed Zaki; Amal Fawzy; Samia Y Akel; H Gamal; Reham A A Elshimy
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.